LB Pharmaceuticals Inc (LBRX)

LB Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	250.17	22.98	14.98	21.4
Short-Term Investments	45.04	5.02	28.31	-
Cash & Short-Term Investments	295.21	28	43.29	21.4
Cash Growth	954.37%	-35.32%	102.26%	-
Prepaid Expenses	2.46	0.46	2.34	0.08
Other Current Assets	10.76	0.42	0.01	0.01
Total Current Assets	308.43	28.88	45.63	21.49
Property, Plant & Equipment	3.73	4.16	0.02	0
Other Long-Term Assets	0.77	0.5	-	-
Total Assets	312.93	33.53	45.66	21.49
Accounts Payable	2.13	2.32	1.39	0.16
Accrued Expenses	4.59	5.3	1.22	0.31
Current Portion of Leases	0.73	0.49	-	-
Total Current Liabilities	7.44	8.11	2.61	0.47
Long-Term Debt	-	-	-	24.15
Long-Term Leases	2.84	3.22	-	-
Other Long-Term Liabilities	1.34	2.5	1.56	18.49
Total Liabilities	11.62	13.83	4.16	43.11
Common Stock	0	0	0	0
Additional Paid-In Capital	430.67	9.66	6.47	6.13
Retained Earnings	-129.53	-104.32	-41.22	-34.95
Comprehensive Income & Other	0.17	0.11	0.27	-
Total Common Equity	301.31	-94.55	-34.47	-28.81
Shareholders' Equity	301.31	19.71	41.49	-21.62
Total Liabilities & Equity	312.93	33.53	45.66	21.49
Total Debt	3.57	3.7	-	24.15
Net Cash (Debt)	291.64	24.3	43.29	-2.74
Net Cash Growth	1100.38%	-43.88%	-	-
Net Cash Per Share	36.25	67.82	173.44	-11.87
Filing Date Shares Outstanding	28.67	0.25	0.25	0.23
Total Common Shares Outstanding	25.3	0.25	0.25	0.23
Working Capital	300.99	20.77	43.03	21.02
Book Value Per Share	11.91	-375.53	-138.11	-124.68
Tangible Book Value	301.31	-94.55	-34.47	-28.81
Tangible Book Value Per Share	11.91	-375.53	-138.11	-124.68
Machinery	0.51	0.47	0.03	0.01
Leasehold Improvements	1.49	1.49	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q